Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

[Why use long-term macrolide therapy in pediatric pulmonology?].

Corvol H, Taytard J, Thouvenin G, Périsson C, Nathan N, Clement A.

Arch Pediatr. 2014 Mar;21(3):314-21. doi: 10.1016/j.arcped.2013.12.023. Epub 2014 Feb 3. French.

PMID:
24503457
2.

Macrolides as immunomodulatory medications for the therapy of chronic lung diseases.

López-Boado YS, Rubin BK.

Curr Opin Pharmacol. 2008 Jun;8(3):286-91. doi: 10.1016/j.coph.2008.01.010. Epub 2008 Mar 12. Review.

PMID:
18339582
3.

Anti-inflammatory effects of macrolides in lung disease.

Jaffé A, Bush A.

Pediatr Pulmonol. 2001 Jun;31(6):464-73. Review.

PMID:
11389580
4.

Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis.

Schultz MJ.

J Antimicrob Chemother. 2004 Jul;54(1):21-8. Epub 2004 Jun 9. Review.

PMID:
15190022
5.

Macrolides and airway inflammation in children.

Shinkai M, Rubin BK.

Paediatr Respir Rev. 2005 Sep;6(3):227-35. Review.

PMID:
16153572
6.

Use of macrolides in lung diseases: recent literature controversies.

Silva Filho LV, Pinto LA, Stein RT.

J Pediatr (Rio J). 2015 Nov-Dec;91(6 Suppl 1):S52-60. doi: 10.1016/j.jped.2015.08.002. Epub 2015 Sep 4. Review.

7.

Macrolides in cystic fibrosis.

McArdle JR, Talwalkar JS.

Clin Chest Med. 2007 Jun;28(2):347-60. Review.

PMID:
17467553
8.

Anti-inflammatory effects of macrolides in childhood lung diseases.

Luisi F, Gandolfi TD, Daudt AD, Sanvitto JP, Pitrez PM, Pinto LA.

J Bras Pneumol. 2012 Nov-Dec;38(6):786-96. Review. English, Portuguese.

9.

Long-term macrolide treatment for chronic respiratory disease.

Spagnolo P, Fabbri LM, Bush A.

Eur Respir J. 2013 Jul;42(1):239-51. doi: 10.1183/09031936.00136712. Epub 2012 Nov 22. Review.

10.

[Usefulness of macrolides as anti-inflammatories in respiratory diseases].

Sevilla-Sánchez D, Soy-Muner D, Soler-Porcar N.

Arch Bronconeumol. 2010 May;46(5):244-54. doi: 10.1016/j.arbres.2009.10.008. Epub 2009 Dec 4. Review. Spanish.

12.

Role of long term antibiotics in chronic respiratory diseases.

Suresh Babu K, Kastelik J, Morjaria JB.

Respir Med. 2013 Jun;107(6):800-15. doi: 10.1016/j.rmed.2013.02.009. Epub 2013 Mar 20. Review.

13.

Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.

Cameron EJ, McSharry C, Chaudhuri R, Farrow S, Thomson NC.

Clin Exp Allergy. 2012 Sep;42(9):1302-12. doi: 10.1111/j.1365-2222.2012.03979.x. Review.

PMID:
22925316
14.

Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.

Zarogoulidis P, Papanas N, Kioumis I, Chatzaki E, Maltezos E, Zarogoulidis K.

Eur J Clin Pharmacol. 2012 May;68(5):479-503. doi: 10.1007/s00228-011-1161-x. Epub 2011 Nov 22. Review.

PMID:
22105373
15.

Macrolides in the treatment of asthma and cystic fibrosis.

Ferrara G, Losi M, Franco F, Corbetta L, Fabbri LM, Richeldi L.

Respir Med. 2005 Jan;99(1):1-10. Review.

PMID:
15672842
16.
17.

Immunomodulatory effects of macrolides: implications for practicing clinicians.

Siddiqui J.

Am J Med. 2004 Nov 8;117 Suppl 9A:26S-29S. Review.

PMID:
15586561
18.

Immunomodulatory activity and effectiveness of macrolides in chronic airway disease.

Rubin BK, Henke MO.

Chest. 2004 Feb;125(2 Suppl):70S-78S. Review.

PMID:
14872003
19.

The role of atypical infections and macrolide therapy in patients with asthma.

Rollins DR, Good JT Jr, Martin RJ.

J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):511-7. doi: 10.1016/j.jaip.2014.06.002. Epub 2014 Aug 3. Review.

PMID:
25213043
20.

Supplemental Content

Support Center